Science & Research

The DEA has proposed massively increasing the production of research-grade cannabis and psychedelics like LSD, psilocybin, and MDMA next year.

Researchers found that less than 2% of people living in states that have legalized cannabis have been diagnosed with “cannabis use disorder” and that the reforms were not linked to increased cannabis consumption among youths aged 12-20.

A recent survey found that 60% of cannabis consumers said they would consume cannabis with their grandparents.

Researchers found that withdrawal effects from synthetic cannabinoids appear more rapidly with consumers reporting more severe symptoms of insomnia, irritation and bad mood, heart palpitations, and loss of appetite.

Cannabis use among college students reached its highest levels in 35 years in 2020, according to the National Institute on Drug Abuse, while alcohol use decreased by 6%.

The DEA last week called for a significant increase in the production of cannabis and psilocybin for the purposes of federal research and clinical trials.

Cannabis use among cancer patients is lower than that of the general public, with just 9% of cancer patients having used cannabis compared to 14% of people with no cancer history according to a new study.

Included in the $1.2 trillion infrastructure bill passed by the Senate on Tuesday are provisions that would let researchers study cannabis from state-licensed dispensaries instead of the low-grade cannabis grown at government facilities.

According to a new study, 15% of remote employees worked from home under the influence of cannabis with the majority reporting benefits like decreased stress and increased creativity.

Pennsylvania-based research firm Affinity Bio Partners is investigating the potential efficacy of cannabis for diabetic nerve pain.

The United Kingdom National Health Service and Brain Tumour Charity are partnering on research to determine whether cannabis-based medicine Sativex paired with chemotherapy medication temozolomide can treat glioblastoma.

HIV-positive patients who consume cannabis daily have lower levels of neuroinflammation than non-cannabis consuming HIV-positive patients, according to a study.

Cannabis use by teens is not independently associated with an increased risk of “amotivational syndrome,” researchers concluded in a recent study.

States that enacted cannabis legalization saw a six-month decline in opioid-related ER visits, according to a recent study.

A new study suggests that cannabis was first domesticated in East Asia during the Neolithic Era and was a multipurpose crop.

Adults aged 18-23-years-old that reside near cannabis retailers are no more likely to be interested in cannabis or tobacco than those who do not, suggests a new study.

California’s legal outdoor cannabis farms use about the same amount of water as other crops and may not use as much water as previously thought, a new study suggests.

Yale University researchers found that a single dose of psilocybin increases the growth of neural connections which are reduced by chronic stress and depression.

A new study published last week in Gynecologic Oncology Reports found 71% of gynecologic cancer patients reported self-improvement while using medical cannabis.

Hemp projects were awarded $194,000 of the $460,000 that comprise Pennsylvania’s Specialty Crop Block Grants.

A new study shows an increase in the number of U.S. military veterans using cannabis, although Veteran Affairs doctors still cannot recommend it to patients at agency-run hospitals.

Accompanying the increase in women purchasers, 6% of 2020 cannabis consumers were new users and a substantial 22% were Gen Zers.

Researchers found about a 20% reduction in the probability that a person reports having any income from workers’ compensation following statewide cannabis legalization.

Goodness Growth Inc. said it will research the effect of “naturally derived” psychedelics on a variety of psychological disorders.